Clinical Trial Update: Stereotactic Body Radiotherapy for Lung Lesions With Markerless Tracking (MLT) on the VERO® SBRT System

View source ↗

Summary

The clinical trial evaluating markerless tracking SBRT for lung lesions on the VERO system has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Non-small Cell Lung Cancer

Snippet

Sponsor: Universitair Ziekenhuis Brussel | Conditions: Lung Cancer, Stereotactic Body Radiotherapy | Status: WITHDRAWN